Calcitonin gene-related peptide release machinery

The Calcitonin gene-related peptide (CGRP) release machinery is a specialized protein assembly responsible for the regulated secretion of CGRP from sensory nociceptors, particularly within the trigeminal ganglion (Durham, 2006). This machinery primarily involves the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment protein REceptor) complex, which consists of proteins such as SNAP-25, Syntaxin-1, and VAMP-2 (synaptobrevin) (Jahn & Scheller, 2006). These proteins facilitate the fusion of CGRP-containing large dense-core vesicles with the neuronal plasma membrane in a calcium-dependent manner (Goadsby et al., 2017). CGRP is a potent vasodilator and a key mediator of neurogenic inflammation and pain transmission, playing a central role in the pathophysiology of migraine and chronic pain (Edvinsson et al., 2018). Therapeutic agents like Botulinum neurotoxin type A (OnabotulinumtoxinA) target this machinery by cleaving SNAP-25, thereby inhibiting the release of CGRP and reducing peripheral and central sensitization (Burstein et al., 2014). This mechanism provides a long-lasting therapeutic effect for patients with chronic migraine by disrupting the neuro-inflammatory signaling cascade (Matak et al., 2011). While highly effective, the use of such toxins requires precise administration to avoid off-target effects like localized muscle weakness or the rare risk of systemic toxin spread.

Other names

CGRP secretory machinerySNARE complex in CGRP-positive neuronsCGRP exocytosis apparatusTrigeminal CGRP release system

Inhibition of neuropeptide exocytosis through proteolytic cleavage of SNARE proteins (e.g., SNAP-25 or VAMP), preventing the fusion of CGRP-containing vesicles with the presynaptic membrane (Burstein et al., 2014; Matak et al., 2011).